In a healthy patient >65 years of age with glioblastoma multiforme, what is the recommendation for temozolomide when given concurrently with adjuvant radiation therapy?

Topics: Radiation Oncology • Neuro-Oncology • Medical Oncology • Neurology

Length of temozolomide course when given with adjuvant radiotherapy

Answer from: Medical Oncologist at Community Practice

Glioblastoma (GBM) is primarily a disease of older adults. The median age of diagnosis is around 60. Many of these patients present with a host of co-morbidities that impact their performance status (PS), overlapping with GBM-related complications. There are multiple scenarios to consider when evalu...

Comments

at Northwell Health
Dr. @Simon Khagi's response is excellent. I follow...

Related Questions